K. Altok

Novel Inflammatory Marker in Dialysis Patients: YKL‐40

M. Y. Tekbudak, Ülver Derici, H. Paşaoğlu, 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Oral Candida Colonization as a Risk Factor for Chronic Inflammation and Atherosclerosis in Hemodialysis Patients

H. Yılmaz, M. Bali, A. Kalkancı, 2019, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Determination of genotoxic effects in hemodialysis patients with chronic kidney disease and the role of diabetes mellitus and other biochemical parameters.

F. Unal, D. Yuzbasioglu, S. Deger, 2019, Mutation research.

Discontinuation of Eculizumab treatment after hematological remission in patients with atypical and drug-induced hemolytic uremic syndrome

U. Derici, G. Guz, T. Arınsoy, 2021, Romanian journal of internal medicine = Revue roumaine de medecine interne.

DNA damage in hemodialysis patients with chronic kidney disease; a test of the role of diabetes mellitus; a comet assay investigation.

F. Unal, D. Yuzbasioglu, S. Deger, 2016, Mutation research. Genetic toxicology and environmental mutagenesis.